Announcement PDF Appendix 4C Quarterly report for entities admitted on the basis of commitments Rule 4.7B Appendix 4C Quarterly report for entities admitted on the basis of commitments Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10 Name of entity Paradigm Biopharmaceuticals Limited ABN Quarter ended (“current quarter”) 94 169 346 963 31 December 2015 Consolidated statement of cash flows Cash flows related to operating activities Current quarter $A’000 Year to date (6 months) $A’000 - 1.1 Receipts from customers - 1.2 Payments for (62) (195) (631) (770) (244) - (602) - 35 - 36 - (902) (1,531) 1.3 1.4 1.5 1.6 1.7 (a) staff costs (b) advertising & marketing (c) research & development (d) leased assets (e) other working capital Dividends received Interest and other items of a similar nature received Interest and other costs of finance paid Income taxes paid Other (provide details if material) Net operating cash flows + See chapter 19 for defined terms. 17/12/2010 Appendix 4C Page 1 Appendix 4C Quarterly report for entities admitted on the basis of commitments Current quarter $A’000 1.8 Year to date (6 months) $A’000 Net operating cash flows (carried forward) (902) (1,531) Cash flows related to investing activities Payment for acquisition of: (a) businesses (item 5) (b) equity investments (c) intellectual property (d) physical non-current assets (e) other non-current assets (32) - (557) - Proceeds from disposal of: (a) businesses (item 5) (b) equity investments (c) intellectual property (d) physical non-current assets (e) other non-current assets - - Loans to other entities Loans repaid by other entities Other (provide details if material) - - Net investing cash flows (32) (557) 1.14 Total operating and investing cash flows (934) (2,088) 1.15 1.16 1.17 1.18 1.19 1.20 Cash flows related to financing activities Proceeds from issues of shares, options, etc. Proceeds from sale of forfeited shares Proceeds from borrowings Repayment of borrowings Dividends paid Other (provide details if material) (141) - 7,370 (141) - (141) 7,229 Net increase (decrease) in cash held (1,075) 5,141 1.21 1.22 Cash at beginning of quarter/year to date Exchange rate adjustments to item 1.20 1.23 Cash at end of quarter 6,341 5,266 125 5,266 1.9 1.10 1.11 1.12 1.13 Net financing cash flows + See chapter 19 for defined terms. Appendix 4C Page 2 17/12/2010 Appendix 4C Quarterly report for entities admitted on the basis of commitments Payments to directors of the entity and associates of the directors Payments to related entities of the entity and associates of the related entities Current quarter $A'000 1.24 Aggregate amount of payments to the parties included in item 1.2 60 1.25 Aggregate amount of loans to the parties included in item 1.11 - 1.26 Explanation necessary for an understanding of the transactions Payments to Chairman and Non-Executive Directors Non-cash financing and investing activities 2.1 Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows N/A 2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest N/A Financing facilities available Add notes as necessary for an understanding of the position. 3.1 Loan facilities 3.2 Credit standby arrangements Amount available $A’000 NIL NIL + See chapter 19 for defined terms. 17/12/2010 Appendix 4C Page 3 Amount used $A’000 NIL NIL Appendix 4C Quarterly report for entities admitted on the basis of commitments Reconciliation of cash Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows. 4.1 Cash on hand and at bank 4.2 Deposits at call 4.3 Bank overdraft 4.4 Other (provide details) Total: cash at end of quarter (item 1.23) Current quarter $A’000 Previous quarter $A’000 5,266 6,341 - - - - - - 5,266 6,341 Acquisitions and disposals of business entities Acquisitions (Item 1.9(a)) Disposals (Item 1.10(a)) 5.1 Name of entity N/A N/A 5.2 N/A N/A N/A N/A 5.4 Place of incorporation or registration Consideration for acquisition or disposal Total net assets N/A N/A 5.5 Nature of business N/A N/A 5.3 Compliance statement 1 This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not required because of note 2) or other standards acceptable to ASX. 2 This statement does give a true and fair view of the matters disclosed. Sign here: Date: 27 January 2016 Company secretary Print name: Kevin Hollingsworth + See chapter 19 for defined terms. Appendix 4C Page 4 17/12/2010 Appendix 4C Quarterly report for entities admitted on the basis of commitments Notes 1. The quarterly report provides a basis for informing the market how the entity’s activities have been financed for the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report. 2. The definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report except for any additional disclosure requirements requested by AASB 107 that are not already itemised in this report. 3. Accounting Standards. ASX will accept, for example, the use of International Financial Reporting Standards for foreign entities. If the standards used do not address a topic, the Australian standard on that topic (if any) must be complied with. + See chapter 19 for defined terms. 17/12/2010 Appendix 4C Page 5